On July 3, Oruka Therapeutics fell 11.21% in regular trading, trading at $83.215 USD/share, with Turnover of $319 million.
Within the Biotechnology sector where Oruka Therapeutics belongs, the overall sector showed broad gains. Among individual stocks, AbbVie up 3.61%, Moderna up 8.61%, Vertex Pharmaceuticals up 5.14%, Abivax up 7.83%, Gilead Sciences up 3.43%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)